BASKING RIDGE, N.J., Jan. 13, 2015 /PRNewswire/ -- Reproductive Medicine Associates of New Jersey ("RMANJ"), world-renowned leaders in the research and treatment of infertility, today announced they have been certified as an Infertility Center of Excellence by CIGNA, one of the largest health insurance providers in the U.S., effective January 1, 2015.
"We are truly proud of this recognition and appreciate CIGNA's ongoing commitment to elevating innovative and results-based infertility care," said Dr. Richard Scott, MD, FACOG, ALD/HCLD, a founding partner at RMANJ. "With the combination of CCS and single embryo transfer (SET) in IVF, we offer both patients and insurance providers, like CIGNA, uncompromised success rates, fewer complicated and costly twin deliveries, and a lower total global cost of care from IVF treatment to delivery."
With IVF delivery rates above 60 percent, nearly 20 percent higher than the national average1, RMANJ supports hopeful patients with the widest range of services including in vitro fertilization (IVF), egg donation, gestational surrogacy, comprehensive chromosome screening (CCS), pre-implantation genetic diagnosis (PGD), fertility preservation services, acupuncture, yoga and patient-to-patient networking.
"Without insurance coverage many hopeful parents can't afford treatment for infertility. And with changes related to the ACA expected to take place this year, we're concerned many more patients could experience new gaps in coverage in 2016. However, we are hopeful that with the CCS and SET data, from RMANJ and other programs across the U.S., more insurance companies will recognize that providing coverage ultimately results in healthier babies, lower-risk pregnancies and massive cost savings for both the patient and insurer," offered Dr. Thomas Molinaro, a partner at RMANJ.
"The data supports a future where insurance companies actually increase infertility benefits by mandating CCS and SET to reduce the clinical, emotional and financial burdens created by IVF multiples," added Dr. Molinaro.
An infertility treatment center can be awarded the CIGNA COE designation through quality of results or a combination of quality of results and cost effectiveness. As part of the CIGNA Centers of Excellence program, patient outcomes and cost-efficiency information is evaluated using the most current publicly reported data from the Centers for Disease Control (CDC) singleton live birth and transfer rates from 2011 and 2012. Cost efficiency is assessed by aggregating claims data related to infertility treatment by cycle type to determine the average cost per cycle by the facility.
ABOUT REPRODUCTIVE MEDICINE ASSOCIATES OF NEW JERSEY
The fertility experts at RMANJ have among the highest IVF success rates in the country (www.sart.org). Since 1999, they have helped bring more than 30,000 babies to loving families. In addition to serving as the Division of Reproductive Endocrinology at Rutgers Robert Wood Johnson Medical School in New Brunswick, NJ (www.reifellowship.com), the practice has seven locations in New Jersey.
RMANJ pioneered and successfully implemented a cutting-edge technology, known as Comprehensive Chromosome Screening (CCS), to more accurately detect healthy embryos that have led to successful pregnancies and ultimately healthy babies. Comprehensive Chromosome Screening (SelectCCS) is owned and operated by the Foundation for the Assessment and Enhancement of Embryonic Competence (www.faeec.org) and offers advanced embryo selection with extreme accuracy by detecting and avoiding use of embryos with chromosomal abnormalities prior to transfer and pregnancy.
For more information please call RMANJ at 973-656-2089, or visit www.rmanj.com.
SOURCE Reproductive Medicine Associates of New Jersey